پوساکونازول (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "پوساکونازول" in Persian language version.

refsWebsite

Global rank Persian rank

4doi.org

2^nd place

4nih.gov

4^th place

5^th place

1elsevier.com

610^th place

762^nd place

1web.archive.org

1^st place

1theannals.com

low place

1oxfordjournals.org

1,389^th place

783^rd place

1jstor.org

26^th place

72^nd place

1fda.gov

447^th place

382^nd place

1archive.today

14^th place

29^th place

1utdol.com

low place

archive.today

Dodds Ashley, Elizabeth; Perfect, John (October 13, 2009). "Pharmacology of azoles". Archived from the original on 9 February 2013. Retrieved 18 February 2010.

doi.org

Schiller DS, Fung HB (September 2007). "Posaconazole: an extended-spectrum triazole antifungal agent". Clin Ther. 29 (9): 1862–86. doi:10.1016/j.clinthera.2007.09.015. PMID 18035188.
Rachwalski EJ, Wieczorkiewicz JT, Scheetz MH (October 2008). "Posaconazole: an oral triazole with an extended spectrum of activity". Ann Pharmacother. 42 (10): 1429–38. doi:10.1345/aph.1L005. PMID 18713852. Archived from the original on 14 December 2019. Retrieved 23 October 2017.
Li X, Brown N, Chau AS, et al. (January 2004). "Changes in susceptibility to posaconazole in clinical isolates of Candida albicans". J. Antimicrob. Chemother. 53 (1): 74–80. doi:10.1093/jac/dkh027. PMID 14657086.
Walsh TJ, Raad I, Patterson TF, et al. (January 2007). "Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial". Clin. Infect. Dis. 44 (1): 2–12. doi:10.1086/508774. JSTOR 4485188. PMID 17143808. – via JSTOR (نیازمند آبونمان)

elsevier.com

linkinghub.elsevier.com

Schiller DS, Fung HB (September 2007). "Posaconazole: an extended-spectrum triazole antifungal agent". Clin Ther. 29 (9): 1862–86. doi:10.1016/j.clinthera.2007.09.015. PMID 18035188.

fda.gov

accessdata.fda.gov

"Drugs at FDA: Noxafil" (PDF). Retrieved 18 February 2010.

jstor.org

Walsh TJ, Raad I, Patterson TF, et al. (January 2007). "Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial". Clin. Infect. Dis. 44 (1): 2–12. doi:10.1086/508774. JSTOR 4485188. PMID 17143808. – via JSTOR (نیازمند آبونمان)

nih.gov

pubmed.ncbi.nlm.nih.gov

Schiller DS, Fung HB (September 2007). "Posaconazole: an extended-spectrum triazole antifungal agent". Clin Ther. 29 (9): 1862–86. doi:10.1016/j.clinthera.2007.09.015. PMID 18035188.
Rachwalski EJ, Wieczorkiewicz JT, Scheetz MH (October 2008). "Posaconazole: an oral triazole with an extended spectrum of activity". Ann Pharmacother. 42 (10): 1429–38. doi:10.1345/aph.1L005. PMID 18713852. Archived from the original on 14 December 2019. Retrieved 23 October 2017.
Li X, Brown N, Chau AS, et al. (January 2004). "Changes in susceptibility to posaconazole in clinical isolates of Candida albicans". J. Antimicrob. Chemother. 53 (1): 74–80. doi:10.1093/jac/dkh027. PMID 14657086.
Walsh TJ, Raad I, Patterson TF, et al. (January 2007). "Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial". Clin. Infect. Dis. 44 (1): 2–12. doi:10.1086/508774. JSTOR 4485188. PMID 17143808. – via JSTOR (نیازمند آبونمان)

oxfordjournals.org

jac.oxfordjournals.org

Li X, Brown N, Chau AS, et al. (January 2004). "Changes in susceptibility to posaconazole in clinical isolates of Candida albicans". J. Antimicrob. Chemother. 53 (1): 74–80. doi:10.1093/jac/dkh027. PMID 14657086.

theannals.com

Rachwalski EJ, Wieczorkiewicz JT, Scheetz MH (October 2008). "Posaconazole: an oral triazole with an extended spectrum of activity". Ann Pharmacother. 42 (10): 1429–38. doi:10.1345/aph.1L005. PMID 18713852. Archived from the original on 14 December 2019. Retrieved 23 October 2017.

utdol.com

Dodds Ashley, Elizabeth; Perfect, John (October 13, 2009). "Pharmacology of azoles". Archived from the original on 9 February 2013. Retrieved 18 February 2010.

web.archive.org

Rachwalski EJ, Wieczorkiewicz JT, Scheetz MH (October 2008). "Posaconazole: an oral triazole with an extended spectrum of activity". Ann Pharmacother. 42 (10): 1429–38. doi:10.1345/aph.1L005. PMID 18713852. Archived from the original on 14 December 2019. Retrieved 23 October 2017.